Antigen
AssigneeOxford Biomedica (UK) Limited
InventorsMiles Carroll, Abigail Lamikanra, Alan Kingsman
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel method for the delivery of agents to tumour cells. In particular it relates to a method for the specific delivery of agents to the interior of tumour cells. Uses of the method are also described.
Claims13
A 5T4 ligand linked to an agent, wherein the agent is Calicheamicin.
8-21. (canceled)
A method for the specific delivery of one or more agents to the interior of a tumour cell comprising the step of contacting a tumour cell a specific 5T4 ligand linked to said one or more agents wherein at least one agent is Calicheamicin.
24-36. (canceled)
A method for the prophylaxis or treatment of cancer in a mammal comprising the step of administering to a mammal in need of such treatment a specific 5T4 ligand linked to a cytoxic agent wherein the cytotoxic agent is Calicheamicin.
38-53. (canceled)
Dependencies are inferred from the claim text.